Home    Back

Hepatitis a vaccine    (DrugBank: Hepatitis A Vaccine)

3 diseases
IDDisease name (Link within this page)Number of trials
46Malignant rheumatoid arthritis4
96Crohn disease1
97Ulcerative colitis1

46. Malignant rheumatoid arthritis    [ 4,183 clinical trials,   2,538 drugs,   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways]
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
4 / 4,183 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01947465
(ClinicalTrials.gov)		October 201322/8/2013Immunogenicity and Safety of Vaccinations in Immunocompromised PersonsA Prospective Cohort Study in 6 Swiss Rheumatology Centres and 4 Travel Clinics on the Immunogenicity and Safety of Tetanus and Hepatitis A Vaccine in Patients With Rheumatoid Arthritis, Axial Spondyloarthritis and Vasculitis and Healthy ControlsArthritis, Rheumatoid;Spondylarthritis;VasculitisBiological: Hepatitis A vaccine and tetanus vaccineUniversity of ZurichUniversity of Basel;Swiss Tropical & Public Health Institute;University of Bern;University Hospital, Geneva;Cantonal Hospital of St. Gallen;Cantonal Hospital of Aarau, SwitzerlandCompleted18 YearsN/ABoth645N/ASwitzerland
2NCT01446978
(ClinicalTrials.gov)		September 20113/10/2011Three Doses of Hepatitis A Vaccine in Patients With Immunomodulating DrugsHepatitis A Vaccination in Patients With Rheumatoid Arthritis Treated With TNF-inhibitors and/or MethotrexateVaccine Response ImpairedBiological: hepatitis A vaccineSormland County Council, SwedenNULLActive, not recruiting18 YearsN/ABoth150Phase 2Sweden
3EUCTR2009-016055-22-SE
(EUCTR)		09/03/201111/01/2011Hepatitis A vaccine in patients with immunomodulative drugsHepatitis A vaccine in patients with immunomodulative drugs Patients with rheumatoid arthritis treated with immunosuppressive medication
MedDRA version: 12.1;Level: LLT;Classification code 10039073;Term: Rheumatoid arthritis
MedDRA version: 12.1;Classification code 10054980;Term: Immunosuppressant drug therapy
MedDRA version: 12.1;Classification code 10063430;Term: Hepatitis A immunisation		Trade Name: Epaxal
Product Name: Epaxal
Other descriptive name: Inactivated hepatitis A virus
Trade Name: Havrix
Product Name: Havrix
Other descriptive name: inactivated hepatitis A virus		HY, HUSNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		380Finland;Sweden
4NCT01360970
(ClinicalTrials.gov)		September 200924/5/2011Hepatitis A Vaccine in Patients With Immunomodulating DrugsHepatitis A Vaccination in Patients With Rheumatoid Arthritis Treated With TNF-inhibitors and/or MethotrexateResponse to Hepatitis A VaccineBiological: hepatitis A vaccine ( HAVRIX or EPAXAL)Lars RomboNULLCompleted18 YearsN/ABoth68Phase 2Finland;Sweden

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01341808
(ClinicalTrials.gov)		April 201125/4/2011Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) PatientsImmunogenicity of Hepatitis A Vaccine in Patients With Inflammatory Bowel DiseaseInflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis;Hepatitis ABiological: Epaxal Berna (virosomal hepatitis A vaccine)Asan Medical CenterNULLCompleted18 Years40 YearsBoth493Phase 4Korea, Republic of

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01341808
(ClinicalTrials.gov)		April 201125/4/2011Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) PatientsImmunogenicity of Hepatitis A Vaccine in Patients With Inflammatory Bowel DiseaseInflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis;Hepatitis ABiological: Epaxal Berna (virosomal hepatitis A vaccine)Asan Medical CenterNULLCompleted18 Years40 YearsBoth493Phase 4Korea, Republic of

Back to top